Literature DB >> 9728421

Medical management of advanced gastric cancer.

M E Hill1, D Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9728421     DOI： 10.1016/s0305-7372(98)90077-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  8 in total

Review 1.  Adenoviral gene therapy in gastric cancer: a review.

Authors:  Nima Khalighinejad; Hesammodin Hariri; Omid Behnamfar; Arash Yousefi; Amir Momeni
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

2.  Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells.

Authors:  DE-Jun Tai; Wen-Sen Jin; Cheng-Si Wu; Hong-Wei Si; Xian-Dong Cao; Ai-Jun Guo; Jia-Cong Chang
Journal:  Exp Ther Med       Date:  2012-05-24       Impact factor: 2.447

Review 3.  From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.

Authors:  Jackie Walling
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.651

4.  Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer.

Authors:  Hiroshi Sakai; Kenoki Ohuchida; Kazuhiro Mizumoto; Lin Cui; Kohei Nakata; Hiroki Toma; Eishi Nagai; Masao Tanaka
Journal:  Ann Surg Oncol       Date:  2011-02-24       Impact factor: 5.344

5.  Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.

Authors:  H J Kang; H M Chang; T W Kim; M-H Ryu; H J Sohn; J H Yook; S T Oh; B S Kim; J-S Lee; Y-K Kang
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

6.  A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.

Authors:  S Cascinu; F Graziano; S Barni; R Labianca; G Comella; R Casaretti; L Frontini; V Catalano; A M Baldelli; G Catalano
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

7.  Tumor microenvironment characterization in stage IV gastric cancer.

Authors:  Xianxue Zhang; Feng Yang; Zhenbao Wang
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

8.  A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer.

Authors:  F Graziano; D Santini; E Testa; V Catalano; G D Beretta; S Mosconi; G Tonini; V Lai; R Labianca; S Cascinu
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.